7733 Stock Overview
Manufactures and sells precision machineries and instruments worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Olympus Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,392.00 |
| 52 Week High | JP¥2,729.00 |
| 52 Week Low | JP¥1,782.00 |
| Beta | 0.63 |
| 11 Month Change | -9.74% |
| 3 Month Change | -4.55% |
| 1 Year Change | 22.70% |
| 33 Year Change | 8.41% |
| 5 Year Change | 88.05% |
| Change since IPO | 614.03% |
Recent News & Updates
Does Olympus (TSE:7733) Have A Healthy Balance Sheet?
Jul 14
Estimating The Fair Value Of Olympus Corporation (TSE:7733)
Jun 28Shareholder Returns
| 7733 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 9.4% | 6.2% | -2.1% |
| 1Y | 22.7% | 12.7% | 6.1% |
Return vs Industry: 7733 exceeded the JP Medical Equipment industry which returned 12.7% over the past year.
Return vs Market: 7733 exceeded the JP Market which returned 6.1% over the past year.
Price Volatility
| 7733 volatility | |
|---|---|
| 7733 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 9.9% |
| 10% least volatile stocks in JP Market | 3.3% |
Stable Share Price: 7733 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7733's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 28,838 | Stefan Kaufmann | www.olympus-global.com |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.
Olympus Corporation Fundamentals Summary
| 7733 fundamental statistics | |
|---|---|
| Market cap | JP¥2.78t |
| Earnings (TTM) | JP¥27.88b |
| Revenue (TTM) | JP¥966.05b |
99.8x
P/E Ratio2.9x
P/S RatioIs 7733 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7733 income statement (TTM) | |
|---|---|
| Revenue | JP¥966.05b |
| Cost of Revenue | JP¥322.62b |
| Gross Profit | JP¥643.42b |
| Other Expenses | JP¥615.54b |
| Earnings | JP¥27.88b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | 23.98 |
| Gross Margin | 66.60% |
| Net Profit Margin | 2.89% |
| Debt/Equity Ratio | 32.2% |
How did 7733 perform over the long term?
See historical performance and comparison